Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,149,000 | 20,878,000 | 16,142,000 | 12,475,000 | 6,197,000 |
| Depreciation Amortization | 1,769,000 | 7,390,000 | 5,547,000 | 3,733,000 | 1,894,000 |
| Income taxes - deferred | -926,000 | -2,079,000 | -2,564,000 | -685,000 | -730,000 |
| Accounts receivable | -421,000 | -2,450,000 | -1,878,000 | -1,618,000 | -1,617,000 |
| Other Working Capital | -2,733,000 | -4,286,000 | -2,730,000 | -6,221,000 | -3,028,000 |
| Other Operating Activity | 1,141,000 | 3,957,000 | 3,161,000 | 1,704,000 | 1,358,000 |
| Operating Cash Flow | $3,979,000 | $23,410,000 | $17,678,000 | $9,388,000 | $4,074,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -359,000 | -2,941,000 | -1,571,000 | -836,000 | -74,000 |
| Net Acquisitions | -252,000 | -60,000 | N/A | N/A | N/A |
| Purchase Of Investment | -9,018,000 | -30,394,000 | -18,843,000 | -12,264,000 | -5,994,000 |
| Sale Of Investment | 6,303,000 | 25,006,000 | 16,809,000 | 12,453,000 | 5,233,000 |
| Other Investing Activity | -308,000 | -294,000 | 282,000 | 43,000 | 650,000 |
| Investing Cash Flow | $-3,634,000 | $-8,683,000 | $-3,323,000 | $-604,000 | $-185,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,019,000 | 1,997,000 | 1,283,000 | 498,000 | 23,000 |
| Debt Issued | N/A | 5,000 | 3,000 | 1,000 | 1,000 |
| Debt Repayment | -2,132,000 | -1,802,000 | -1,452,000 | -1,451,000 | -1,001,000 |
| Common Stock Issued | 321,000 | 1,036,000 | 808,000 | 543,000 | 236,000 |
| Common Stock Repurchased | -1,577,000 | -3,456,000 | -2,460,000 | -2,069,000 | -1,438,000 |
| Dividend Paid | -2,787,000 | -11,032,000 | -8,241,000 | -5,450,000 | -2,659,000 |
| Other Financing Activity | -1,229,000 | -795,000 | -552,000 | -476,000 | -287,000 |
| Financing Cash Flow | $-4,385,000 | $-14,047,000 | $-10,611,000 | $-8,404,000 | $-5,125,000 |
| Exchange Rate Effect | 16,000 | -178,000 | -125,000 | -33,000 | -78,000 |
| Beginning Cash Position | 14,487,000 | 13,985,000 | 13,985,000 | 13,985,000 | 13,985,000 |
| End Cash Position | 10,463,000 | 14,487,000 | 17,604,000 | 14,332,000 | 12,671,000 |
| Net Cash Flow | $-4,024,000 | $502,000 | $3,619,000 | $347,000 | $-1,314,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,979,000 | 23,410,000 | 17,678,000 | 9,388,000 | 4,074,000 |
| Capital Expenditure | -607,000 | -3,652,000 | -2,237,000 | -1,490,000 | -677,000 |
| Free Cash Flow | 3,372,000 | 19,758,000 | 15,441,000 | 7,898,000 | 3,397,000 |